A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Incyte Corporation
Incyte Corporation
Dana-Farber Cancer Institute
Janssen Research & Development, LLC
National Cancer Institute (NCI)
Servier
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ruijin Hospital
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group